The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
Made up of a group of original thinkers with non-traditional backgrounds, QVT brings a broad perspective and unique expertise to smart, diverse investment.
Venture capitalNew York, NY, USAqvt.comSince 2025-12-18
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Syremis Therapeutics Syremis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health. | Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $165M | 2025-12-18 | [ PART ] |
No sector on record.